Akoya Biosciences Unveils Strategic Product Roadmap
Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels
The new offerings solidify leadership in spatial biology and broaden reach to new verticals
Akoya Biosciences, a frontrunner in spatial proteomics, has announced an exciting product roadmap designed to enhance research capabilities. This new roadmap includes advanced ultrahigh-plex neurobiology panels for human and mouse applications, extending their highly regarded lineup that features the Human IO60 and Mouse FFPE IO Panels.
Innovative Products for Groundbreaking Research
The recent introduction of the PhenoCode™ Discovery IO60 panel has already made waves in the scientific community. Celebrated by industry experts and contract research organizations, this panel provides critical insights into immune landscapes and tumor-immune interactions.
Notable quotes from leading researchers emphasize its transformative potential. Dr. Simon Knott from Cedars-Sinai noted, “The IO60 panel may reshape spatial proteomics and open new avenues for immune research.” Similarly, Dr. Suzuki Yutaka of the University of Tokyo remarked that the IO60 panel uncovers previously inaccessible patterns in immune responses, heralding a new era for tumor-immune interaction studies.
Furthermore, strategic partnerships with prominent CROs such as Precision for Medicine, BostonGene, and Infinity Scope have accelerated the adoption of the IO60 panel, effectively integrating it into their core research services. This collaboration ensures that advanced spatial proteomics tools are accessible to a broader spectrum of researchers.
Introducing the Ultrahigh-Plex Neurobiology Panels
Following the success of the IO60, Akoya has exciting plans to launch the PhenoCode Human and Mouse FFPE Neurobiology panels. Scheduled for release in the upcoming quarters, these new panels will enable researchers to gain vital spatial insights into critical areas such as neurodegenerative diseases and therapeutic developments.
Key Features of the New Neurobiology Panels
- Human Neurobiology Panel: This high-plex spatial proteomics tool is designed to explore biomarkers related to neurodegeneration, neuroinflammation, and key therapeutic targets, thus propelling neuroscience research forward.
- Mouse Neurobiology Panel: Tailored for preclinical applications, this panel boasts an extensive set of biomarkers, facilitating studies on neurodevelopment and disease modeling.
- Seamless Integration with PhenoCycler-Fusion: Fully optimized for the PhenoCycler-Fusion platform, these panels will ensure rapid and high-resolution insight generation, further enhancing research capabilities.
CEO Brian McKelligon commented, “The swift expansion of our PhenoCycler-Fusion offerings reflects the efficiency of our Manufacturing Center of Excellence. These ready-to-use high-plex panels will empower researchers to bridge the gap from discovery to translational research.”
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences focuses on providing powerful solutions for spatial phenotyping that add context to biological research and human health. Their range of single-cell imaging tools enables scientists to visualize phenomena like disease progression and responses to therapies. By offering an all-encompassing set of spatial phenotyping solutions like the PhenoCode™ Panels and PhenoCycler®, Akoya serves diverse research needs efficiently.
Frequently Asked Questions
What is the focus of Akoya Biosciences' new product roadmap?
Akoya's new product roadmap aims to enhance research capabilities with innovative ultrahigh-plex neurobiology panels and other advanced spatial proteomics tools.
How are the IO60 panel and new neurobiology panels expected to impact research?
The IO60 panel is reshaping spatial proteomics, while the new neurobiology panels will provide critical spatial insights needed for advancements in neurodegenerative research.
Who benefits from Akoya's products?
Researchers from various fields including oncology, inflammatory diseases, and neurobiology can benefit significantly from Akoya's advanced spatial proteomics solutions.
What platforms does Akoya's equipment integrate with?
Akoya's new panels are fully integrated with the PhenoCycler-Fusion platform, known for its rapid and high-resolution capabilities in spatial proteomics.
Where can I learn more about Akoya Biosciences?
You can learn more about Akoya Biosciences and their innovative products by visiting their official website.
